首页> 外文期刊>Tissue engineering, Part C. Methods >Evaluation of the structural integrity and extracellular matrix components of tracheal allografts following cyclical decellularization techniques: Comparison of three protocols
【24h】

Evaluation of the structural integrity and extracellular matrix components of tracheal allografts following cyclical decellularization techniques: Comparison of three protocols

机译:循环脱细胞技术对气管同种异体移植物结构完整性和细胞外基质成分的评估:三种方案的比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tracheal reconstruction is indicated in cases of malignancy, traumatic injury, and subglottic or tracheal stenosis. Recent progress in airway transplantation has provided renewed optimism for potential solutions for defects involving more than half of the tracheal length in adults or one-third of the tracheal length in children. Biologic scaffolds derived from decellularized tissues and organs have shown great promise in tracheal allotransplantation, and cyclical decellularization techniques have been hypothesized as abrogating the need for immunosuppressive therapy. In this study, we performed a direct comparison of three decellularization protocols (Protocols A, B, and C) previously described in the literature, two of which were described in tracheal tissue (Protocols A and B). We concentrated on the immunogenicity within the epithelium and mucosa, quantified and qualified the extracellular matrix (ECM) components, and performed compliance measurements on large circumferential decellularized tracheal scaffolds following cyclical decellularization techniques using all three protocols. Quantitative measurements of glycosaminoglycans (GAGs) showed a significant decrease in the mucosal component following 17 cycles of all 3 protocols as well as a significant decrease of GAGs in the cartilaginous component following cycles 1, 9, and 17 of Protocol A and cycle 17 of Protocol C. Compliance measurements were also shown to be different between the protocols, with grafts becoming more compliant at physiologic pressures after cyclical decellularization with Protocols A and B and slightly less compliant but remaining similar to native trachea using Protocol C. Positive staining for anti-major histocompatibility complex Class I (anti-MHCI) and anti-MHCII remained within the submucosal glandular components despite multiple cycles of decellularization using all three protocols. This study illustrated that there are significant differences in ECM composition and resultant structural integrity of decellularized tracheal scaffolds depending on the decellularization protocol. Protocol B was shown to maintain the GAGs components despite an increase in tracheal compliance, while Protocol C decreases GAGs components following multiple cycles, despite showing a tracheal compliance resembling that of the native trachea at physiologic airway pressures.
机译:气管重建适用于恶性肿瘤,外伤性损伤以及声门下或气管狭窄。气道移植的最新进展为潜在的解决方案提供了新的乐观方法,这些解决方案涉及成年人气管长度一半以上或儿童气管长度三分之一的缺陷。来自脱细胞组织和器官的生物支架在气管同种异体移植中显示出了巨大的希望,并且已经假设循环脱细胞技术可以消除对免疫抑制疗法的需求。在这项研究中,我们直接比较了先前文献中描述的三种脱细胞方案(方案A,B和C),其中两个在气管组织中进行了描述(方案A和B)。我们集中于上皮和粘膜内的免疫原性,量化并鉴定了细胞外基质(ECM)成分,并使用所有三种方案,根据循环脱细胞技术对大周向脱细胞气管支架进行了顺应性测量。糖胺聚糖(GAG)的定量测​​量显示,在所有3个方案的17个循环后,粘膜成分均明显降低,在方案A的第1、9和17个周期以及该方案的第17个周期后,软骨成分中的GAG显着降低。 C.规程之间的依从性测量也显示出差异,在使用规程A和B进行周期性脱细胞后,移植物在生理压力下变得更加顺应,而柔顺性稍差,但仍与使用规约C的天然气管相似。尽管使用所有三种方案进行了多次脱细胞循环,但组织相容性复合物I类(抗MHCI)和抗MHCII仍保留在粘膜下腺成分内。这项研究表明,脱细胞气管支架的ECM组成和所得结构完整性存在显着差异,具体取决于脱细胞方案。尽管气管顺应性增加,方案B仍能维持GAGs成分,而协议C在多次循环后仍能降低GAGs组分,尽管在生理气道压力下气管顺应性与天然气管相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号